1 |
EVANS M. Discovering pluripotency: 30 years of mouse embryonic stem cells[J]. Nat Rev Mol Cell Biol, 2011, 12(10): 680-686.
|
2 |
STEWART C L, KASPAR P, BRUNET L J, et al. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor[J]. Nature, 1992, 359(6390): 76-79.
|
3 |
SHAHBAZI M N, ZERNICKA-GOETZ M. Deconstructing and reconstructing the mouse and human early embryo[J]. Nat Cell Biol, 2018, 20(8): 878-887.
|
4 |
YANG F, HUANG X, ZANG R, et al. DUX-miR-344-ZMYM2-mediated activation of MERVL LTRs induces a totipotent 2C-like state[J]. Cell Stem Cell, 2020, 26(2): 234-250.e7.
|
5 |
LI M, BELMONTE J C I. Ground rules of the pluripotency gene regulatory network[J]. Nat Rev Genet, 2017, 18(3): 180-191.
|
6 |
TOSIC J, KIM G J, PAVLOVIC M, et al. Eomes and Brachyury control pluripotency exit and germ-layer segregation by changing the chromatin state[J]. Nat Cell Biol, 2019, 21(12): 1518-1531.
|
7 |
CHO S W, KIM S, KIM J M, et al. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease[J]. Nat Biotechnol, 2013, 31(3): 230-232.
|
8 |
DOUDNA J A, CHARPENTIER E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9[J]. Science, 2014, 346(6213): 1258096.
|
9 |
DETTMER R, NAUJOK O. Design and derivation of multi-reporter pluripotent stem cell lines via CRISPR/Cas9n-mediated homology-directed repair[J]. Curr Protoc Stem Cell Biol, 2020, 54(1): e116.
|
10 |
RYAN M D, KING A M, THOMAS G P. Cleavage of foot-and-mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequence[J]. J Gen Virol, 1991, 72(Pt 11): 2727-2732.
|
11 |
DE FELIPE P, LUKE G A, BROWN J D, et al. Inhibition of 2A-mediated 'cleavage' of certain artificial polyproteins bearing N-terminal signal sequences[J]. Biotechnol J, 2010, 5(2): 213-223.
|
12 |
VERES A, FAUST A L, BUSHNELL H L, et al. Charting cellular identity during human in vitro β-cell differentiation[J]. Nature, 2019, 569(7756): 368-373.
|
13 |
SALEH-GOHARI N, HELLEDAY T. Conservative homologous recombination preferentially repairs DNA double-strand breaks in the S phase of the cell cycle in human cells[J]. Nucleic Acids Res, 2004, 32(12): 3683-3688.
|
14 |
FU R J, XIANYU Y L. Gold nanomaterials-implemented CRISPR-cas systems for biosensing[J]. Small, 2023: e2300057.
|
15 |
TANG W F, TRAN A T, WANG L Y, et al. SARS-CoV-2 pandemics: an update of CRISPR in diagnosis and host-virus interaction studies[J]. Biomed J, 2023, 46(2): 100587.
|
16 |
GODBOUT K, TREMBLAY J P. Prime editing for human gene therapy: where are we now?[J]. Cells, 2023, 12(4): 536.
|
17 |
MOLLASHAHI B, LATIFI-NAVID H, OWLIAEE I, et al. Research and therapeutic approaches in stem cell genome editing by CRISPR toolkit[J]. Molecules, 2023, 28(4): 1982.
|
18 |
YAMAGUCHI T P, TAKADA S, YOSHIKAWA Y, et al. T (Brachyury) is a direct target of Wnt3a during paraxial mesoderm specification[J]. Genes Dev, 1999, 13(24): 3185-3190.
|